Lonitoclax

N/A

Report date: 2024/10/10 11:20:27
NME

Base Information

Drug NameLonitoclax
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitors
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEilean Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesLomond Therapeutics IncEilean Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, AcuteLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A